| Style | Citing Format |
|---|---|
| MLA | Mirzaei HR, et al.. "Corrigendum: Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications." Frontiers in immunology, vol. 10, no. , 2019, pp. 780-. |
| APA | Mirzaei HR, Rodriguez A, Shepphird J, Brown CE, Badie B (2019). Corrigendum: Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications. Frontiers in immunology, 10(), 780-. |
| Chicago | Mirzaei HR, Rodriguez A, Shepphird J, Brown CE, Badie B. "Corrigendum: Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications." Frontiers in immunology 10, no. (2019): 780-. |
| Harvard | Mirzaei HR et al. (2019) 'Corrigendum: Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications', Frontiers in immunology, 10(), pp. 780-. |
| Vancouver | Mirzaei HR, Rodriguez A, Shepphird J, Brown CE, Badie B. Corrigendum: Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications. Frontiers in immunology. 2019;10():780-. |
| BibTex | @article{ author = {Mirzaei HR and Rodriguez A and Shepphird J and Brown CE and Badie B}, title = {Corrigendum: Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications}, journal = {Frontiers in immunology}, volume = {10}, number = {}, pages = {780-}, year = {2019} } |
| RIS | TY - JOUR AU - Mirzaei HR AU - Rodriguez A AU - Shepphird J AU - Brown CE AU - Badie B TI - Corrigendum: Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications JO - Frontiers in immunology VL - 10 IS - SP - 780 EP - PY - 2019 ER - |